Skip to main content

Find Clinical Trials

Home
Conditions
Intermediate- and High-risk Myelofibrosis (MF) Patients With Splenomegaly

Clinical trial condition

Intermediate- and High-risk Myelofibrosis (MF) Patients With Splenomegaly

Explore clinical trials studying Intermediate- and High-risk Myelofibrosis (MF) Patients With Splenomegaly. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Intermediate- and High-risk Myelofibrosis (MF) Patients With Splenomegaly trial results

Active, Not Recruiting

A Study to Evaluate Safety , Efficacy and Pharmacokinetics of WJ01024 Tablets Combined With Ruxolitinib in Patients With Myelofibrosis

NCT06909136

Conditions: Intermediate- and High-risk Myelofibrosis (MF) Patients With Splenomegaly
Locations: Henan Cancer Hospital Zhengzhou, China

View Trial Details